Major new NHS medical alliance aims to put North East
at centre of pioneering research
Newcastle
University teams up with hospital trusts to attract leading medical research
into diseases and improve outcomes for patients
![]() |
NHS Hospital Chief Executive Sir Leonard Fenwick |
A new alliance has been formed
to deliver “trailblazing health services” and make the North East a centre of
pioneering medical research.
The partnerships aims to
harness world-class expertise, ensuring patients in the region benefit sooner
from new treatments and earlier diagnoses.
Bringing together Newcastle Hospitals and Northumberland, Tyne and Wear
NHS Foundation Trusts and Newcastle University, the newly-formed ‘Newcastle Academic
Health Partners’ hopes to deliver pioneering healthcare through scientific
research, education and patient care.
The new alliance will be
focusing on leading the way in scientific advances to tackle common diseases
such as dementia. It will also specialise in improving understanding and
treatment of cancer, diseases that affect the brain and those affecting
children.
Sir Leonard Fenwick, chief
executive for the Newcastle Hospitals, said: “Newcastle has a long-standing,
international reputation for delivering trailblazing health services. This
wouldn’t be possible without the leading edge research carried out in
partnership with Newcastle University, and we very much see this formal
partnership, alongside new partners Northumberland, Tyne and Wear NHS
Foundation Trust, as a springboard to cultivate even more pioneering research
to benefit the people of the North East and beyond.”
John Lawlor, chief executive
of Northumberland, Tyne and Wear NHS Foundation Trust, said: “Our service users
have already benefited from research carried out in partnership with Newcastle
University and we are excited about the opportunities provided by this formal
partnership to deliver world-leading research to benefit people around the
world.”
The partners have developed a
five year plan that includes recruiting and training the next generation of
researchers and providing national leadership in healthcare education. This
collaborative approach is helping attract some of the brightest researchers and
practitioners to Newcastle and the North East region.
Professor Chris Day, pro vice
chancellor in the Faculty of Medical Sciences at Newcastle University, said:
“This partnership is at the forefront of translating scientific advances made
at Newcastle University into direct benefits for patients.
“This strategy has already led
to major advances in healthcare within the region, as well as nationally and
internationally”.
Patients with Chronic Fatigue
Syndrome (CFS) are already benefitting from the medical expertise provided by
newly formed alliance.
Professor Julia Newton,
clinical professor of Ageing and Medicine at Newcastle University, who also
works within Newcastle upon Tyne Hospitals NHS Foundation Trust, has led a team
of experts who have found an abnormality of a protein which could lead to the
development of new drugs and treatments.
Researchers found that
patients with the condition have a defect in a molecule associated with the
production of a protein known as AMP kinase (AMPK) – the first time such a
discovery has been made which will provide greater understanding of CFS.
Professor Newton said: “At the
moment we don’t know what causes CFS and, as a result, there are no
biological-based treatments that can be given to patients.
“There are a great number
suffering significant problems with CFS and our work is heading towards looking
for medications that we can use to improve patients’ symptoms and hopefully
find a cure.”
![]() |
Kirsty Harwood who suffers from CFS |
CFS is a common condition that
affects approximately 600,000 people in the UK. It causes crippling fatigue,
often with severe muscle pain that does not go away, and can create long-term
disability.
Professor Newton added: “A
real strength in the North East is that the university and hospital trusts work
closely together, pulling on each other’s academic and clinical strengths so
that we can be sure our work is of the very highest quality to help patients.”
One patient who knows
first-hand the importance of the CFS research being carried out is Kirsty
Harwood who was diagnosed with the condition a year ago, after suffering
symptoms for a number of months.
The mother-of-two, from High
Heaton, Newcastle, has welcomed the research breakthrough brought about by
Newcastle Academic Health Partners.
Kirsty, 46, an Environment
Agency worker, said: “When you’re diagnosed with the condition you feel
isolated as there is no treatment or cure and it turns your life upside down.
“I went from being a fully independent
working mum, to becoming dependent on my partner to look after me and my two
daughters in the space of two weeks. We don’t know what, and may never know
what, caused it just that we now have to deal with it.
“The research that’s going on
in the North East is exciting and offers real hope to those suffering with the
illness that a treatment may become available.
“It would be amazing for
people, and their families, if medication could be established to treat the
debilitating symptoms that we have to deal with each day.”